Get started
Author

Ermanno Rondini

Acupuncture As an Integrative Approach for the Treatment of Hot Flashes in Women With Breast Cancer: A Prospective Multicenter Randomized Controlled Trial (AcCliMaT)
2016 · Grazia Lesi, Giorgia Razzini, et al. · Journal of Clinical Oncology · 124
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
2014 · E. Bajetta, I. Floriani, et al. · Annals of Oncology · 93
PDF
Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-α (IFN-α) in Operable Renal Cell Carcinoma (RCC): A Phase III, Randomized, Multicentre Trial of the Italian Oncology Group for Clinical Research (GOIRC)
2014 · Rodolfo Passalacqua, Caterina Caminiti, et al. · Journal of Immunotherapy · 85
Conservative surgery with and without radiotherapy in elderly patients with early-stage breast cancer: A prospective randomised multicentre trial
2009 · C. Tinterri, W. Gatzemeier, et al. · The Breast · 65
PDF
Breast-Conservative Surgery With and Without Radiotherapy in Patients Aged 55–75 Years With Early-Stage Breast Cancer: A Prospective, Randomized, Multicenter Trial Analysis After 108 Months of Median Follow-up
2013 · C. Tinterri, W. Gatzemeier, et al. · Annals of Surgical Oncology · 49
Beyond Lockdown: The Potential Side Effects of the SARS-CoV-2 Pandemic on Public Health
2021 · Sara Paltrinieri, Barbara Bressi, et al. · Nutrients · 31
PDF
Characteristics of the case mix, organisation and delivery in cancer palliative care: a challenge for good-quality research
2016 · M J Hjermstad, N Aass, et al. · BMJ Supportive & Palliative Care · 28
PDF
Adjuvant low-dose interleukin-2 (IL2) plus interferone-alpha (IFN) in operable renal cell cancer (RCC). A phase III, randomized, multicenter, independent trial of the Italian Oncology Group for Clinical Research (GOIRC)
2007 · R. Passalacqua, C. Buzio, et al. · Journal of Clinical Oncology · 27
Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancer
2012 · Marco Montanari, Francesco Fabbri, et al. · Tumori Journal · 23
Is early integration of palliative care feasible and acceptable for advanced respiratory and gastrointestinal cancer patients? A phase 2 mixed-methods study
2017 · Massimo Costantini, Giovanni Apolone, et al. · Palliative Medicine · 20
PDF
Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S) trial: Comparison of a sequential treatment with irinotecan (CPT-11) plus 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer.
2012 · Emilio Bajetta, Irene Floriani, et al. · Journal of Clinical Oncology · 15
Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study
2002 · M Colozza, G Bisagni, et al. · European Journal of Cancer · 14
Impact on Survival of Timing and Duration of Adjuvant Chemotherapy in Radically Resected Gastric Cancer
2016 · Maria Di Bartolomeo, Filippo Pietrantonio, et al. · Tumori Journal · 13
Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomes
2005 · G. Cocconi, B. Di Blasio, et al. · Annals of Oncology · 12
PDF
Severe Rhabdomyolysis during Treatment with Trabectedin in Combination with a Herbal Drug in a Patient with Metastatic Synovial Sarcoma: A Case Report
2017 · Angela Damato, Mario Larocca, et al. · Case Reports in Oncology · 11
PDF
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study)
2021 · Elisa Giommoni, Evaristo Maiello, et al. · Current Oncology · 10
PDF
Randomized trial comparing cyclophosphamide, methotrexate, and 5–fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma
2002 · Giorgio Cocconi, Beatrice Di Blasio, et al. · Cancer · 9
Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: A phase II study of the Italian oncology group for clinical research (goirc)
2000 · C. Boni, G. Bisagni, et al. · International Journal of Cancer · 9
Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S) trial: Comparison of a sequential treatment with irinotecan (CPT-11) plus 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer.
2012 · Emilio Bajetta, Irene Floriani, et al. · Journal of Clinical Oncology · 8
Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01–2014)
2017 · Rodolfo Passalacqua, Silvia Lazzarelli, et al. · BMC Cancer · 6
PDF
Neoadjuvant Chemotherapy with Continuous Infusion of Cisplatin and Fluorouracil in Stage II-IV, M0 Squamous Cell Carcinoma of the Head and Neck
1996 · Corrado Boni, Gabriella Moretti, et al. · Tumori Journal · 6
Abstract LB-226: mTOR inhibition by Temsirolimus as second-line treatment for advanced RCC: The Medical optimization of Torisel® (MoTOR) phase II trial by the Italian Kidney Cancer Group (GIR)
2012 · Michele Milella, Alessandra Felici, et al. · Cancer Research · 5
Activities Carried Out during the First COVID-19 Lockdown by Italian Citizens
2023 · Sara Paltrinieri, Barbara Bressi, et al. · International Journal of Environmental Research and Public Health · 4
PDF
Role and challenges to digital technologies in community health promotion programs in Italy during the COVID-19 pandemic: a multiple embedded case study protocol.
2023 · Marco Del Riccio, Luigi Costantini, et al. · Acta bio-medica dell'Ateneo parmense/Acta biomedica · 4
PDF
Vinflunine (VFL) in patients (pts) with metastatic transitional cell carcinoma of the urothelial tract (mTCCU): Clinical outcome and prognostic factors in a nationwide, real-life setting (MOVIE trial).
2016 · Rodolfo Passalacqua, Silvia Lazzarelli, et al. · Journal of Clinical Oncology · 4
Works count: 48
Citation count: 697
H-index: 13
I10-index: 16
Year
Topic
Type